17ß-Estradiol Saliva ELISA
- Regulatory Status
- EU: CE IVDR
- Kit size
- 12 x 8
- Method
- ELISA
- Incubation time
- 2 x 1 h, 1 x 30 min
- Standard range
- 2 - 64 pg/mL
- Specimen / Volumes
- 50 µL Saliva
- Substrate / isotope
- TMB 450 nm
Improved Saliva Testing of hormone levels
Enzyme immunoassay for the quantitative measurement of 17beta-Estradiol in human saliva.
The 17-beta-Estradiol Saliva ELISA is intended for the measurement of 17-beta-Estradiol in human saliva. Estradiol is the most important natural estrogen and present in both women and men. The measurement of the hormone level is useful for detection of estrogen deficiency. Estradiol has an impact on puberty, primary and secondary amenorrhea and menopause. This test is not intended for assessing placental function in complicated pregnancy. Additional hormone assays are recommended for an interpretation of the estradiol level.
The 17-beta-Estradiol Saliva ELISA is based on the competition principle and measured on an absorbance reader. The assay is semi-automated requiring general purpose laboratory instruments and consumables such as absorbance microplate reader/washer, vortexer and pipettes to execute the test. Test results may be calculated manually from a standard curve and compared to laboratory established reference ranges from healthy adults (i.e. normal ranges). The device can be adapted to different ELISA processors and can be applied to open automated platforms like EVOlyzer®.
The test kit is intended for professional laboratory use by trained personnel. The test kit is not for home or lay person use. The test kit is intended for manual use.
Benefits of the 17ß-Estradiol Saliva ELISA
Mass spectrometry (MS) is considered as the reference for steroid hormone quantification. This methodology does however represent a large investment and as such is not available to all laboratories. The main Tecan saliva assays have been developed to correlate to this reference method, and even more importantly, only require low sample volume for quantification of the steroid hormones.

Our Saliva ELISA product line (Cortisol, Testosterone, Progesterone, 17beta Estradiol, Estriol, DHEA) can be processed in a similar way and be easily performed in combination:
*Provided the same lot number for each component is used. Valid lot numbers of TMB, stop solution and wash solution are stated on the kits outer labels and Quality Control certificates.
The 17beta Estradiol Saliva ELISA (Cat. No. 30121045) can be adapted on different ELISA processors. Open automated platforms like the EVOlyzer® from Tecan have been tested and show good correlation to the manual runs:

Estradiol is secreted into circulation by the ovaries, placenta, adrenal gland, and testes or is produced by extra-glandular conversion of secreted androgen precursors. Estradiol is biologically the most active of the naturally produced human estrogens. In the postmenopausal women, Estradiol originates from extra-glandular conversion of androgens and circulates in low, non-cyclic concentrations.
In prepubescent children and in males, salivary Estradiol concentrations are low and non-cyclic. The changes in the hormone levels are registered during the different the phases of the menstrual cycle.

Similar to Testosterone and Progesterone, 17ß-Estradiol also shows short time pulsating dynamics, especially in females. Therefore single saliva determinations will result in arbitrary values. We recommend collecting 3 to 5 saliva samples within 2 hours. In the laboratory, equal volumes of the individual saliva samples can be mixed. This mixed sample results in a mean 17ß-Estradiol value, which represents the active hormone concentration in a reproducible way.
17beta-Estradiol [1, 3, 5 (10) -estratriene-3, 17beta-diol; E2] is a C18 steroid hormone and an important natural estrogen, which derives from the precursor cholesterol and belongs to the group steroid hormones called estrogens, which is present in women and men [1; 2]. Estradiol is the major estrogen in the body involving different functions within the human physiology throughout life [3]. Estradiol, the most potent bioactive estrogen, is primarily synthesized from testosterone in the ovarian follicles in females, whereas in males it is produced by the testes and extraglandular conversion of androgens [4; 5]. Estradiol is synthesized from testosterone or estrone, a derivative of cholesterol [6].
The main hormones responsible for advancing secondary sexual characteristics are two androgens: testosterone and dehydroepiandrosterone (DHEA), which facilitate masculine development, and estradiol, an estrogen which facilitates feminine development [7]. Estradiol is the primary estrogen released from the gonads and other peripheral tissues [8].
Levels of 17beta-Estradiol secretion increased with pubertal progression. Estradiol is an important hormone present in both women and men. Estrogen deficiency in boys and in girls but especially in young girls it has an impact on puberty. Girls with delayed puberty show advancing pubertal maturation when administered estradiol. The measurement of estradiol levels is useful regarding puberty to investigate if early puberty (precocious puberty) occurs in girls. Estradiol is 4-9 times higher in late adolescent girls as compared to childhood [9]. Ovarian volumes increase with pubertal breast stage and correlate positively with circulating estradiol levels [10].
Amenorrhea is classified into primary and secondary amenorrhea. Primary amenorrhea is defined as the absence of menarche by the age of 14 years, while secondary amenorrhea describes the absence of menses for more than six months in previously menstruating women [11]. In older women estrogens level should be observed in regards to menopause [12]. Additionally, estradiol plays a role in ovulation, menstrual cycle and menopause and in this regard the function of ovaries and placenta [13-17].
In addition to its role as a natural hormone, estradiol is used in the realm of hormone replacement therapy during menopause [18].
Naturally estradiol levels both in women and men decline with age, however, the estradiol level in older men are higher than in postmenopausal women and serve different functions in the male body (bone maturation and sex interest). Estradiol levels are related to body fat mass, bone health, affect skin metabolism and sex interest in men. Estradiol levels in men are higher than in postmenopausal women and comparable to estradiol levels in the early follicular phase. It is also worth mentioning that a correlation between testosterone and estradiol levels exists due to testosterone being the major precursor of estradiol [19].
Additional parameters should be measured for an interpretation of the results e.g. DHEA or testosterone [7]. Other physiological aspects where estradiol is involved are amenorrhea (primary and secondary) and menopause, which are indicated by low estradiol levels [11; 21].
In serum steroid hormones are bound to sex hormone binding globulin (SHBG) and to serum albumin, only 1-3% of estradiol circulates in plasma and is present in its free form. Only this portion represents the bioactive form of the endocrine regulation. However, in saliva only the free hormone is present as the protein bound hormones cannot pass the membranes into the oral cavity.
A good correlation between hormones in saliva with the free fraction in serum [20]. Proportions of estradiol levels in saliva are similar, between 0.2% and 7.9% of total serum concentrations [22]. Therefore, the measurement of estradiol in saliva is very attractive for clinicians due to its manifold advantages over venipuncture—being non-invasive, less stressful for the patient, multiple samples can be collected by a layperson after a short introduction.
Steroid hormones have distinct circadian rhythms, especially estradiol and progesterone in females are strongly correlated with the menstrual cycle [23; 24].
For concrete data please consult the Instruction for Use in the download box on the top right side.
[2] Greenspan, F. S., & Gardner, D. G. (2001). Basic and clinical endocrinology.
[3] Gavrilova, N., & Lindau, S. T. (2009). Salivary sex hormone measurement in a national, population-based study of older adults. Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 64(suppl_1), i94-i105.
[4] Mendoza, K., Curran, M., Salimetrics, L. L. C., & Lindau, S. T. (2007). Salivary Estradiol Measurement in Wave I of the Social Life Health & Aging Project. J Gerontol B Psychol Sci Soc Sci. 2009 Nov; 64B(Suppl 1): i94–i105. doi: 10.1093/geronb/gbn028
[5] Tivis, L. J., Richardson, M. D., Peddi, E., & Arjmandi, B. (2005). Saliva versus serum estradiol: implications for research studies using postmenopausal women. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(5), 727-732.
[6] Jameson JL, De Groot LJ (25 February 2015). Endocrinology: Adult and Pediatric E-Book. Elsevier Health Sciences. p. 2179. ISBN 978-0-323-32195-2.
[7] Shirtcliff, E. A., Dahl, R. E., & Pollak, S. D. (2009). Pubertal development: correspondence between hormonal and physical development. Child development, 80(2), 327-337.
[8] Fernández-Garcia, B., Lucia, A., Hoyos, J., Chicharro, J. L., Rodriguez-Alonso, M., Bandres, F., & Terrados, N. (2002). The response of sexual and stress hormones of male pro-cyclists during continuous intense competition. International journal of sports medicine, 23(08), 555-560.
[9] Ikegami, S., Moriwake, T., Tanaka, H., Inoue, M., Kubo, T., Suzuki, S., ... & Seino, Y. (2001). An ultrasensitive assay revealed age‐related changes in serum oestradiol at low concentrations in both sexes from infancy to puberty. Clinical endocrinology, 55(6), 789-795.
[10] Kang, J. Y., Park, J. Y., Chun, S. I., Suh, H. S., Lee, K., & Ahn, R. S. (2014). Puberty-related changes in cortisol, dehydroepiandrosterone, and estradiol-17β secretions within the first hour after waking in premenarcheal girls. Neuroendocrinology, 99(3-4), 168-177.
[11] McIver, B., Romanski, S. A., & Nippoldt, T. B. (1997, December). Evaluation and management of amenorrhea. In Mayo Clinic Proceedings (Vol. 72, No. 12, pp. 1161-1169). Elsevier.
[12] Buckler, H. (2005). The menopause transition: endocrine changes and clinical symptoms. British Menopause Society Journal, 11(2), 61-65.
[13] Goletiani, N. V., Keith, D. R., & Gorsky, S. J. (2007). Progesterone: Review of safety for clinical studies. Experimental and clinical psychopharmacology, 15(5), 427.
[14] Bowen R (2000-08-06). "Placental Hormones". Retrieved 2020-29-12. http://www.vivo.colostate.edu/hbooks/pathphys/reprod/placenta/endocrine.html
[15] Hall, J. E. (2004). Neuroendocrine control of the menstrual cycle. In J. F. Strauss, III, & R. L. Barbieri (Eds.), Yen and Jaffe’s reproductive endocrinology: Physiology, pathophysiology, and clinical management (5th ed., pp. 195–211). Philadelphia: Elsevier
[16] Cable, J. K., & Grider, M. H. (2020). Physiology, Progesterone. StatPearls
[17] Frank, G. R. (2003). Role of estrogen and androgen in pubertal skeletal physiology. Medical and pediatric oncology, 41(3), 217-221.
[18] Herrera et al., 2017: Herrera, A. Y., Hodis, H. N., Mack, W. J., & Mather, M. (2017). Estradiol therapy after menopause mitigates effects of stress on cortisol and working memory. The Journal of Clinical Endocrinology & Metabolism, 102(12), 4457-4466
[19] Vermeulen, A., Kaufman, J. M., Goemaere, S., & Van Pottelberg, I. (2002). Estradiol in elderly men. The aging male, 5(2), 98-102.
[20] Dielen, C., Fiers, T., Somers, S., Deschepper, E., & Gerris, J. (2017). Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI. Facts, views & vision in ObGyn, 9(2), 85.
[21] Lu, Y. C., Bentley, G. R., Gann, P. H., Hodges, K. R., & Chatterton, R. T. (1999). Salivary estradiol and progesterone levels in conception and nonconception cycles in women: evaluation of a new assay for salivary estradiol. Fertility and sterility, 71(5), 863-868.
[22] Bacon, J. L. (2017). The menopausal transition. Obstetrics and Gynecology Clinics, 44(2), 285-296.
[23] Gandara, B. K., Leresche, L., & Mancl, L. (2007). Patterns of salivary estradiol and progesterone across the menstrual cycle. Annals of the New York Academy of Sciences, 1098, 446.
[24] Schmidt, J., Wenzel, F., & Blessing, F. (2020) Practical evaluation of two commercial immunoassays for the quantification of steroid hormones in human saliva. Journal of Cellular Biotechnology, (Preprint), 1-9.
[25] Shirtcliff, E. A., D. A. Granger, et al. (2000). "Assessing estradiol in biobehavioral studies using saliva and blood spots: simple radioimmunoassay protocols, reliability, and comparative validity." Horm Behav 38(2): 137-47
[26] Quaiser‐Pohl, C., Jansen, P., Lehmann, J., & Kudielka, B. M. (2016). Is there a relationship between the performance in a chronometric mental‐rotations test and salivary testosterone and estradiol levels in children aged 9–14 years?. Developmental psychobiology, 58(1), 120-128.
[27] Choe, J. K., Khan-Dawood, F. S., & Yusoff-Dawood, M. (1983). Progesterone and estradiol in the saliva and plasma during the menstrual cycle. American journal of obstetrics and gynecology, 147(5), 557-562
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
At Tecan, we are driven to improve people’s lives and health.